Resources Contact Us Home
Internalizing anti-CD74 antibodies and methods of use

Image Number 15 for United States Patent #7931903.

The present invention provides humanized, chimeric and human anti-CD74 antibodies, CD74 antibody fusion proteins, immunoconjugates, vaccines and bispecific that bind to CD74, the major histocompatibility complex (MHC) class-II invariant chain, Ii, which is useful for the treatment and diagnosis of B-cell disorders, such as B-cell malignancies, other malignancies in which the cells are reactive with CD74, and autoimmune diseases, and methods of treatment and diagnosis.

  Recently Added Patents
Semiconductor device and method of manufacturing the same
Organic metal complex and its use in organic electroluminescent device
Wireless communication apparatus, a method of wireless communication, and a program for wireless communication
High-order harmonic device of cavity filter
Methods of enhancing diabetes resolution
Magnetic detection of small entities
Apparatus for focus beam analysis of high power lasers
  Randomly Featured Patents
Monitoring of chemical species in solution and apparatus therefor
Front face of a vehicle wheel
Fluid purification system with low temperature purifier
Suspension, head gimbal assembly with a multilayered and reinforced suspension and disk drive apparatus with head gimbal assembly
Identification means for slings
Manufactured item for the building industry
Semiconductor device and manufacturing method thereof
Embossing assembly for high pressure laminate surfaces
Self-locking threaded member and method
Variable serving size insulated packaging